2202 ⎘
Animals characterised by species; Mammal Swine
HUMANIZATION OF BETA2-MICROGLOBULIN IN PORCINE GENOME RESULTING IN FUNCTIONAL EXPRESSION OF HUMAN BETA2-MICROGLOBULIN WITHIN DONOR CELLS, TISSUES, OR ORGANS
#2CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#3METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163
#4MEASURING THE PROGRESS OF CARDIAC XENOGRAFT IMMUNE REJECTION
#5GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
#6THYMOCYTE HUMANIZED ANIMALS, METHODS OF MAKING AND METHODS OF USE THEREOF
#7CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#8PERSONALIZED CELLS, TISSUES, AND ORGANS FOR TRANSPLANTATION FROM A HUMANIZED, BESPOKE, DESIGNATED-PATHOGEN FREE, (NON-HUMAN) DONOR AND METHODS AND PRODUCTS RELATING TO SAME
#9THERAPEUTIC APPLICATIONS OF CRISPR TYPE V SYSTEMS
#10METHOD OF GENETIC MANIPULATION OF NEURAL CELLS IN GYRENCEPHALIC FETAL BRAIN AND USES THEREOF
#11ANIMAL EAR TAG AND METHOD FOR PRODUCING SUCH AN ANIMAL EAR TAG AND USE OF AN ANTIMICROBIAL ADDITIVE FOR PRODUCING AN AN-IMAL EAR TAG AND USE OF AN ANIMAL EAR TAG WITH AN ANTIMICROBI-AL ADDITIVE
#12PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED CD163 GENES
#13BILIARY ATRESIA MODEL
#14BRAIN TUMOR MODEL
#15HEAT LAMP
#16TRIPLE TRANSGENIC PIGS SUITABLE FOR XENOGRAFT
#17Genetic Modifications for Xenotransplantation
#18EDITING TMPRSS2/4 FOR DISEASE RESISTANCE IN LIVESTOCK
#19GENE-EDITING METHODS FOR GENETIC IMPROVEMENT IN LIVESTOCK
#20METHODS FOR GENERATING GENETICALLY MODIFIED ANIMALS
#21Multiplexed Genome Editing
#22pAPN mutant and composition for site-directed modification of pAPN gene and application thereof
#23NON-MEIOTIC ALLELE INTROGRESSION
#24Kit for breeding a TGEV infection resistant pig and use thereof
#25METHODS FOR MAKING GENETIC EDITS
#26PIG XENOTRANSPLANTS INTO HUMANS WITHOUT CHRONIC IMMUNOSUPPRESSION
#27PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS RESISTANT ANIMALS
#28SGRNA AND CONSTRUCTING DUAL PIG MODEL OF SEVERE IMMUNODEFICIENCY AND LIVER INJURY AND USE THEREOF
#29DOUBLE KNOCKOUT (GT/CMAH-KO) PIGS, ORGANS AND TISSUES
#30GENETICALLY ENGINEERED SWINE FOR PRECLINICAL VALIDATION
#31Pathogen-resistant animals having modified CD163 genes
#32CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE
#33LIVESTOCK ANIMALS WITH IMPROVED GROWTH PERFORMANCE
#34GENERATION OF SURROGATE SIRES AND DAMS BY ABLATION OF ENDOGENOUS GERMLINE
#35JAK3 GENE-MUTATED, SEVERE COMBINED IMMUNODEFICIENCY ANIMAL MODEL AND CONSTRUCTION METHOD THEREFOR
#36TMPRSS KNOCKOUT SWINE HAVING A REDUCED SUSCEPTIBILITY TO INFLUENZA
#37INFLUENZA A-RESISTANT ANIMALS HAVING EDITED ANP32 GENES
#38GENETIC MODIFICATIONS FOR XENOTRANSPLANTATION
#39ETV2 AND USES THEREOF
#40PRECISE BREEDING METHODS FOR GENE-EDITED NON-HUMAN ANIMALS
#41METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163
#42MULTITRANSGENIC PIGS COMPRISING TEN GENETIC MODIFICATIONS FOR XENOTRANSPLANTATION
#43ANIMAL STERILIZATION BY ESTROGENIC COMPOUNDS
#44GRNA FOR KNOCKING OUT PIG XENOANTIGEN GENE, AND APPLICATION THEREOF
#45PRIMATIZED RODENT
#46Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
#47PREVENTION OF BOAR TAINT AND AGGRESSION
#48METHODS FOR LOWERING THE INCIDENCE OF HEMORRHAGIC HEART DISEASE IN SWINE
#49DONOR PIGS FOR XENOTRANSPLANTATION
#50TRANSGENIC SWINE, METHODS OF MAKING AND USES THEREOF, AND METHODS OF MAKING HUMAN IMMUNE SYSTEM MICE
#51CELLS, TISSUES, ORGANS, AND/OR ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND/OR TOLERANCE
#52TRANSGENIC CLONED PIG FOR XENOTRANSPLANTATION EXPRESSING HUMAN CD46 AND TBM GENES, IN WHICH PORCINE ENDOGENOUS RETROVIRUS ENVELOPE C IS NEGATIVE AND GGTA1, CMAH, iGb3s AND ß4GalNT2 GENES ARE KNOCKED OUT, AND METHOD FOR PREPARING SAME
#53MULTI-TRANSGENIC PIGS WITH GROWTH HORMONE RECEPTOR KNOCKOUT FOR XENOTRANSPLANTATION
#54MODELING ONCOLOGY ON DEMAND
#55Identification of porcine xenoantigens
#56GENETIC MODIFICATION OF PIGS FOR XENOTRANSPLANTATION
#57Methods for improving the health of porcine species by targeted inactivation of CD163
#58PORCINE SEXED SEMEN AND METHODS OF USE
#59GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
#60TRANSGENIC MODELS FOR STEM CELL THERAPIES
#61GENETICALLY MODIFIED PIGS FOR XENOTRANSPLANTATION OF VASCULARIZED XENOGRAFTS AND DERIVATIVES THEREOF
#62METHODS AND MATERIALS FOR REDUCING CARDIAC XENOGRAFT REJECTION
#63GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
#64Methods for making genetic edits
#65IMMUNOLOGICALLY COMPATIBLE CELLS, TISSUES, ORGANS, AND METHODS FOR TRANSPLANTATION FOR SILENCING, HUMANIZATION, AND PERSONALIZATION WITH MINIMIZED COLLATERAL GENOMIC DISRUPTIONS
#66METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163
#67Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
#68Method for improving intestinal flora
#69METHOD FOR DEVELOPING ORGAN THAT LACKS SPECIFIC FUNCTIONAL CELL
#70METHODS FOR PROTECTING PORCINE FETUSES FROM INFECTION WITH PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV)
#71TRANSGENIC PIG ISLETS AND USES THEREOF FOR TREATING DIABETES
#72COMPOSITIONS AND METHODS RELATED TO REPORTER SYSTEMS AND LARGE ANIMAL MODELS FOR EVALUATING GENE EDITING TECHNOLOGY
#73DWARFISM ANIMAL MODEL HAVING IGF-1 GENETIC MUTATION AND METHOD FOR PRODUCING SAME
#74Porcine Thy1 gene promoter specifically expressed in neurons
#75Pig with a genetically modified CD163 gene resistant to PRRSv
#76PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS RESISTANT ANIMALS
#77BLOOD PRODUCT DERIVED FROM GENE KNOCKOUT PIG AND USE THEREOF
#78PRODUCTION METHOD FOR ANIMAL MODELS WITH DISEASE ASSOCIATED PHENOTYPES
#79Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
#80GENERATION OF HUMAN ENDODERMAL ORGANS IN PIG MODEL USING LINEAGE RESTRICTED ENDODERMAL PRECURSORS
#81Livestock animals with improved growth performance
#82Biogas production from excrement
#83NON-MEIOTIC ALLELE INTROGRESSION
#84HUMANIZED HEART MUSCLE
#85Humanized skeletal muscle
#86Non-Human Animal Model of Non-Alcoholic Fatty Liver Disease
#87Pathogen-resistant animals having modified CD163 genes
#88Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
#89Multiplexed genome editing
#90Double knockout (GT/CMAH-KO) pigs, organs and tissues
#91Semirigid poultry and/or swine enclosure
#92Method for preparing a large animal model with peritoneal carcinomatosis
#93SEPARATION DEVICE FOE EMISSION REDUCTION IN STABLES AND ANIMAL STABLE
#94INDUCIBLE DISEASE MODELS METHODS OF MAKING THEM AND USE IN TISSUE COMPLEMENTATION
#95CRISPR/Cas9 vector combination and application thereof in gene knockout
#96METHOD AND VECTORS FOR INTRODUCING A GENETIC MUTATION INTO A NON-HUMAN ANIMAL USING A HUMANIZED GENETIC CONSTRUCT
#97In vitro immune synapse system and method of in vitro evaluating immune response using the same
#98Method for generating a genetically modified pig with inactivated porcine endogenous retrovirus (PERV) elements
#99VENTILATION SYSTEM FOR PIG-RAISING FACILITIES
#100Genetically modified cells, tissues, and organs for treating disease
#101Large animal model for developing therapeutic agents to treat impaired ophthalmic function in usher syndrome
#102Method for preparing porcine fibroblasts with both CD163 gene and CD13 gene being knocked-out
#103Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
#104Cold-resistant and lean-type transgenic pig and preparation method therefor
#105NANOS knock-out that ablates germline cells
#106PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED AMINOPEPTIDASE N (ANPEP) GENES
#107IN VITRO IMMUNE SYNAPSE SYSTEM AND METHOD OF IN VITRO EVALUATING IMMUNE RESPONSE USING THE SAME
#108Kidney production method
#109PREVENTION OF BOAR TAINT AND AGGRESSION
#110Multiplexed genome editing
#111Method for developing organ that lacks specific functional cell
#112Methods for increasing genetic progress in a line or breed of swine using sex-selected sperm cells
#113Porcine reproductive and respiratory syndrome virus resistant animals
#114Separation device for emission reduction in stables and animal stable
#115Ungulates with genetically modified immune systems
#116Recombinant adenovirus-based interferon biotherapeutics in swine
#117Swine Comprising Modified CD163 and Associated Methods
#118ENGINEERING OF HUMANIZED CAR T-CELL AND PLATELETS BY GENETIC COMPLEMENTATION
#119Non-meiotic allele introgression
#120Methods of Genetic Modification of a Cell
#121Multiplexed genome editing
#122GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
#123GENETICALLY STERILE ANIMALS
#124Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)
#125ANIMAL MODELS OF CANCER
#126Engineering of Humanized Kidney by Genetic Complementation
#127Genetically modified cells, tissues, and organs for treating disease
#128IDENTIFICATION OF PORCINE XENOANTIGENS
#129Genetically Edited Animal
#130USE OF BRCA1 AND/OR JAML GENES IN PREDICTING INTRAMUSCULAR FAT CONTENT OF PORK AND IN SELECTIVE BREEDING OF PIGS
#131ANIMAL MODELS FOR POLYCYSTIC KIDNEY DISEASE
#132Methods for increasing genetic progress in a line or breed of swine using sex-selected sperm cells
#133PHARMACOKINETIC ANIMAL MODEL
#134Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase
#135Intestinal flora improvement agent
#136Biomarkers for resistance to porcine circovirus 2 associated disease
#137Transgenic cloned piglet expressing human proinsulin and method of producing the same
#138Pathogen-resistant animals having modified CD163 genes
#139Biogas production from excrement
#140Transgenic pig which simultaneously expresses HO-1 gene and TNFR1-Fc gene, and comprises knocked-out GGTA1 gene, and use thereof
#141Shed, in particular for holding pigs
#142Porcine reproductive and respiratory syndrome virus resistant animals
#143Porcine animals lacking expression of functional alpha 1, 3 galactosyltransferase
#144PRODUCTION OF FMDV-RESISTANT LIVESTOCK BY ALLELE SUBSTITUTION
#145Multiplexed genome editing
#146Genetically-Edited Swine
#147Porcine Thy1 gene promoter specifically expressed in neurons
#148Multi-Transgenic Pig for Xenotransplantation
#149MULTIPLEX GENE EDITING
#150TRANSGENIC PIGS WITH GENETIC MODIFICATIONS OF SLA
#151Humanized skeletal muscle
#152Humanized heart muscle
#153Method for producing blood chimeric animal
#154Multiplexed genome editing
#155Double knockout (GT/CMAH-KO) pigs, organs and tissues
#156Genetic marker for determining meat quality traits of pigs and use thereof
#157Method and compositions for synchronizing time of insemination in gilts
#158A METHOD OF SITE-DIRECTED INSERTION TO H11 LOCUS IN PIGS BY USING SITE-DIRECTED CUTTING SYSTEM
#159Disease model pig exhibiting stable phenotype, and production method thereof
#160Artificial oocyte activation
#161Genetically modified cells, tissues, and organs for treating disease
#162ANIMAL MODELS FOR CARDIOMYOPATHY
#163Genetic modification of pigs for xenotransplantation
#164Genetically modified pig cells with an inactivated Etv2 gene
#165Porcine reproductive and respiratory syndrome virus resistant animals
#166B4GALNT2 knock out pig
#167Organ for transplantation and organ structure
#168Method for identifying wuzhishan miniature pig inbred line by using 145 SNPs
#169TRIPLE TRANSGENIC PIGS SUITABLE FOR XENOGRAFT
#170Methods for increasing genetic progress in a line or breed of swine using sex-selected sperm cells
#171Transgenic pig models of cystic fibrosis
#172TRANSGENIC PIGS LACKING ONE OR MORE CELLULAR TRANSPORT GENES
#173Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity
#174Pig model for diabetes
#175Transgenic pig islets and uses thereof for treating diabetes
#176Targeted genome editing in zygotes of domestic large animals
#177ENGINEERING OF HUMANIZED CAR T-CELL AND PLATELETS BY GENETIC COMPLEMENTATION
#178NANOS KNOCK-OUT THAT ABLATES GERMLINE CELLS
#179Expression cassette and vector comprising Alzheimer's disease-related mutant genes and cell line transformed by means of same
#180Pancreatic islets of transgenic LEA29Y animals for treating diabetes
#181Pathogen-resistant animals having modified CD163 genes
#182Interleukin 2 receptor gamma gene targeting vector, production of immune cell-deficient transgenic cloned mini pig having vector introduced therein, preparation method therefor and use thereof
#183Recombination activating gene 2 gene targeting vector, production of SCID-like miniature pigs by TALEN-mediated gene targeting and use thereof
#184Feeder-free method for culture of bovine and porcine spermatogonial stem cells
#185Multi-transgenic pigs for diabetes treatment
#186Immunocompromised ungulates
#187METHODS AND MATERIALS FOR PRODUCING TRANSGENIC ARTIODACTYLS
#188Immune competent models of human disease
#189Genetically modified cells, tissues, and organs for treating disease
#190Domain 5 of CD163 for use in antiviral compositions against PRRS, and transgenic animals
#191Compositions, methods, and devices for dialysis
#192Animal Models of Ataxia-Telangiectasia (A-T)
#193MULTIPLEX GENE EDITING
#194Animal models of cancer
#195Genetically edited pigs comprising a modification in the RELA gene
#196Method and compositions for synchronizing time of insemination in gilts
#197HUMANIZED TRANSGENIC SINGLE NUCLEOTIDE POLYMORPHISM ANIMAL SYSTEMS
#198Method of Preventing or Reducing Virus Transmission in Animals
#199Double knockout (GT/CMAH-KO) pigs, organs and tissues
#200Genetic test and genetic basis for SCID in pigs
#201Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase
#202Fumarylacetoacetate hydrolase (Fah)-deficient pigs and uses thereof
#203Feeder-free method for culture of bovine and porcine spermatogonial stem cells
#204Reducing immunogenicity of xenogeneic transplant tissues
#205Artificial oocyte activation
#206Methods for increasing genetic progress in a line or breed of swine using sex-selected sperm cells
#207Methods of modulating thrombocytopenia and modified transgenic pigs
#208CYB5 AND CYP17 MUTATIONS FOR ALTERATION OF 16-ANDROSTENE STEROID SYNTHESIS AND REDUCED BOAR TAINT IN PIGS
#209Miniature swine transgenic for one or more coagulation factors
#210Porcine Animals Lacking Any Expression of Functional Alpha 1,3 Galactosyltransferase
#211Porcine CD28 receptor, gene for encoding same, and application of same
#212TRANSGENIC ANIMALS WITH CUSTOMIZABLE TRAITS
#213GENETICALLY STERILE ANIMALS
#214SWINE GENETICALLY MODIFIED WITH SPECIFICITY FOR LDL-R KNOCKOUT
#215METHOD AND MATERIALS FOR PRODUCING A GENETICALLY MODIFIED ANIMAL
#216Transgenic pig models of cystic fibrosis
#217Animal models of duchenne muscular dystrophy
#218Porcine reproductive and respiratory syndrome virus resistant animals
#219Production of FMDV-resistant livestock by allele substitution
#220Transgenic pig expressing sTNFR1-Fc genes and the uses thereof
#221Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
#222Methods for increasing genetic progress in a line or breed of swine using sex-selected sperm cells
#223Animal models of atherosclerosis
#224Transgenic ungulates expressing CTLA4-IG and uses thereof
#225Fumarylacetoacetate hydrolase (fah)-deficient pigs and uses thereof
#226Implantation of a cardiac xenograft from a B4GALNT2KO and GTKO transgenic pig to reduce immunogenicity
#227METHOD FOR CULTIVATING A TRANSGENIC ANIMAL WITH INCREASED EXPRESSION AMOUNT OF PORCINE GROWTH HORMONE
#228Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs
#229Method for auxiliary identification of inbred line of wuzhishan miniature pig and its special primer
#230Tissue Products Derived From Animals Lacking Any Expression of Functional Alpha 1, 3 Galactosyltransferase
#231Transgenic pig in which HO-1 and TNFR1-Fc are simultaneously expressed, and method for producing same
#232Porcine Animals Lacking Any Expression of Functional Alpha 1,3 Galactosyltransferase
#233Method for preparing a transgenic animal of simultaneous multiple-gene expression
#234GENETICALLY MODIFIED ANIMALS AND METHODS FOR MAKING THE SAME
#235Methods and materials for producing transgenic artiodactyls
#236Transgenic pig model of cystic fibrosis
#237Immunocompromised Ungulates
#238Anticoagulant fusion protein anchored to cell membrane
#239Transgenic Prothrombin And Related Thrombin Precursors And Transgenics, Methods, Compositions, Uses And The Like Relating Thereto
#240NUCLEAR RECEPTOR SENSOR SYSTEM IN TRANSGENIC ANIMAL
#241METHOD FOR EVALUATION OF DIFFERENTIATION ABILITY OF STEM CELL
#242Gene of porcine alpha-s1 casein, a promoter of the same and use thereof
#243METHODS AND MATERIALS FOR PRODUCING TRANSGENIC ARTIODACTYLS
#244LED lighting for livestock development
#245COMPOSITIONS FOR AND METHODS OF GRAZYME B INHIBITION
#246Multi-transgenic pigs for diabetes treatment
#247PORCINE GENOME EDITING WITH ZINC FINGER NUCLEASES
#248TRANSGENIC PROTEINS FROM MULTI-GENE SYSTEMS, METHODS, COMPOSITIONS, USES AND THE LIKE RELATING THERETO
#249TREATMENT OF FIBROSES AND LIVER DISORDERS
#250Transgenic production in bovine saliva
#251Selecting animals for parentally imprinted traits
#252Using cytosine deaminases to diminish retroelement transfer from pigs to humans
#253MAMMARY GLAND- SPECIFIC HUMAN ERYTHEROPOIETIN EXPRESSION VECTOR, TRANSGENIC ANIMAL AND METHOD FOR PRODUCING HUMAN ERYTHROPOIETIN USING SAME
#254Pig whose genome comprises a heterologous site-specific recombination site and a transpohon tag
#255Method for producing a transgenic pig using a hyper-methylated transposon
#256Transgenic pig as a model of Alzheimer's disease
#257Pig model for atherosclerosis
#258Large Animal Model for Human-Like Advanced Atherosclerotic Plaque
#259PIG MODEL FOR PSORIASIS
#260PIG MODEL FOR BREAST CANCER, MITOCHONDRIA RELATED PROTEIN FOLDING DISORDERS AND/OR EPIDERMOLYSIS BULLOSA SIMPLEX
#261Cancer Compositions, Animal Models, and Methods of Use Thereof
#262Ungulates with genetically modified immune systems
#263GROWTH OF FOREIGN CELLS AFTER CONDITIONAL AND SELECTIVE DESTRUCTION OF FETAL HOST CELLS
#264PORCINE ADENOVIRUS E1 AND E4 REGIONS
#265Transgenic pig model for a hereditary neurodegenerative autosomal dominant disease
#266Transgenic Pig with Diabetes and Method for Producing the Same
#267Transgenic porcine models of cystic fibrosis
#268Production of high levels of transgenic factor IX without gene rescue, and its therapeutic uses
#269Method of identifying compounds using a transgenic pig model of cystic fibrosis
#270Transgenic pig with altered incretin function
#271EXPRESSION OF ACTIVE HUMAN FACTOR IX IN MAMMARY TISSUE OF TRANSGENIC ANIMALS
#272Transgenic Mammals Expressing Human Preproinsulin
#273Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling
#274Transgenic Ungulates Expressing CTLA4-IG and Uses Thereof
#275Method For Preparing An Organ For Transplantation
#276MOLECULAR SEQUENCE OF SWINE RETROVIRUS AND METHODS OF USE
#277Method for the transfer of episomal vectors into animal cells
#278Method and composition for genetically modifying non-human cells and animals
#279USING CYTOSINE DEAMINASES TO DIMINISH RETROELEMENT TRANSFER FROM PIGS TO HUMANS
#280PORCINE CMP-N-ACETYLNEURAMINIC ACID HYDROXYLASE GENE
#281Method of producing cloned animals by demecolcine treatment
#282Construction of Arterial Occlusive Disease Animal Model
#283Swine population having low levels of porcine endogenous retrovirus and uses thereof
#284Pluripotent cells from rat and other species
#285Expression constructs expressing Prkag3
#286Method for Genetic Improvement of Terminal Boars
#287Ungulates with genetically modified immune systems
#288Animal Bioreactors
#289ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor
#290Porcine pancreatic amylase gene promoter and transgenic pigs expressing heterologous digestive enzymes
#291Animal model for type II diabetes mellitus and Syndrome X and methods and uses thereof
#292Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascualr disorders
#293Method of Identifying Therapeutic Compounds Which Can Be Used for the Treatment and/or Prevention of Infections and Diseases Caused by Human Herpesviruses
#294Follistatin gene as a genetic marker for reproductive and performance traits in pigs
#295Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells
#296Methods and compositions for inhibition of immune responses
#297Compositions for and methods of granzyme B inhibition
#298Using cytosine deaminases to diminish retroelement transfer from pigs to humans
#299Genetic markers for skatole metabolism
#300Expression vector for hirudin and transformed cells and transgenic animals containing said vector